🇺🇸 FDA
Pipeline program

304 injection

SSGJ-304-NHL-I-02

Phase 1 small_molecule active

Quick answer

304 injection for CD20 Positive B Cell NHL is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
CD20 Positive B Cell NHL
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials